Neuroepithelial, Perineurial, and Schwann Cell Neoplasm

Neuroepithelial, Perineurial, and Schwann Cell Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

3,131 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 151–200 of 471 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT02330562	Stage 1: Marizomib + Bevacizumab in WHO Gr IV GBM; Stage 2: Marizomib Alone; Stage 3: Combination of Marizomib and Bevacizumab	completed	Phase 1 / Phase 2	121	CelgeneINDUSTRY	2	Jun 8, 2022	clinicaltrials
NCT01434602	Phase I-II Everolimus and Sorafenib in Recurrent High-Grade Gliomas	completed	Phase 1 / Phase 2	86	National Cancer Institute (NCI)NIH	1	Jun 1, 2022	clinicaltrials